292 related articles for article (PubMed ID: 29687317)
1. The effects of heart rate control in chronic heart failure with reduced ejection fraction.
Grande D; Iacoviello M; Aspromonte N
Heart Fail Rev; 2018 Jul; 23(4):527-535. PubMed ID: 29687317
[TBL] [Abstract][Full Text] [Related]
2. Novel drugs for heart rate control in heart failure.
Bielecka-Dabrowa A; von Haehling S; Rysz J; Banach M
Heart Fail Rev; 2018 Jul; 23(4):517-525. PubMed ID: 29594814
[TBL] [Abstract][Full Text] [Related]
3. [Chronic Heart Failure With Preserved Ejection Fraction: Effective Treatment Possible?].
Kanorskiy SG; Borisenko YV
Kardiologiia; 2018 Jun; 58(6):85-89. PubMed ID: 30362441
[TBL] [Abstract][Full Text] [Related]
4. Limited role and benefit of ivabradine in the treatment of angina and heart failure with reduced ejection fraction.
Ennezat PV; Cosgrove S; Marechaux S; Bouvaist H; Le Jemtel TH; Vital Durand D
Acta Cardiol; 2017 Dec; 72(6):664-668. PubMed ID: 28656798
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.
Bouabdallaoui N; O'Meara E; Bernier V; Komajda M; Swedberg K; Tavazzi L; Borer JS; Bohm M; Ford I; Tardif JC
ESC Heart Fail; 2019 Dec; 6(6):1199-1207. PubMed ID: 31591826
[TBL] [Abstract][Full Text] [Related]
6. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure - J-SHIFT Study.
Tsutsui H; Momomura SI; Yamashina A; Shimokawa H; Kihara Y; Saito Y; Hagiwara N; Ito H; Yano M; Yamamoto K; Ako J; Inomata T; Sakata Y; Tanaka T; Kawasaki Y;
Circ J; 2019 Sep; 83(10):2049-2060. PubMed ID: 31391387
[TBL] [Abstract][Full Text] [Related]
8. Ivabradine in Management of Heart Failure: a Critical Appraisal.
Orasanu G; Al-Kindi SG; Oliveira GH
Curr Heart Fail Rep; 2016 Feb; 13(1):60-9. PubMed ID: 26797824
[TBL] [Abstract][Full Text] [Related]
9. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
[TBL] [Abstract][Full Text] [Related]
10. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
Perry CM
Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
[TBL] [Abstract][Full Text] [Related]
11. The Use and Indication of Ivabradine in Heart Failure.
Dodd K; Lampert BC
Heart Fail Clin; 2018 Oct; 14(4):493-500. PubMed ID: 30266358
[TBL] [Abstract][Full Text] [Related]
12. Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure.
Pereira-Barretto AC
Adv Ther; 2015 Oct; 32(10):906-19. PubMed ID: 26521191
[TBL] [Abstract][Full Text] [Related]
13. Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction.
Reil JC; Reil GH; Böhm M
Trends Cardiovasc Med; 2009 Jul; 19(5):152-7. PubMed ID: 20005474
[TBL] [Abstract][Full Text] [Related]
14. The Importance of Heart Rate in Heart Failure and Reduced Ejection Fraction.
Prasun MA; Albert NM
J Cardiovasc Nurs; 2018; 33(5):453-459. PubMed ID: 29621054
[TBL] [Abstract][Full Text] [Related]
15. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients.
Reil JC; Tardif JC; Ford I; Lloyd SM; O'Meara E; Komajda M; Borer JS; Tavazzi L; Swedberg K; Böhm M
J Am Coll Cardiol; 2013 Nov; 62(21):1977-1985. PubMed ID: 23933545
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
Imamura T; Hori M; Narang N; Besser S; Kinugawa K
Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological heart rate lowering in patients with a preserved ejection fraction-review of a failing concept.
Meyer M; Rambod M; LeWinter M
Heart Fail Rev; 2018 Jul; 23(4):499-506. PubMed ID: 29098508
[TBL] [Abstract][Full Text] [Related]
18. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Swedberg K; Komajda M; Böhm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
Lancet; 2010 Sep; 376(9744):875-85. PubMed ID: 20801500
[TBL] [Abstract][Full Text] [Related]
19. Heart rate and its reduction in chronic heart failure and beyond.
Nikolovska Vukadinović A; Vukadinović D; Borer J; Cowie M; Komajda M; Lainscak M; Swedberg K; Böhm M
Eur J Heart Fail; 2017 Oct; 19(10):1230-1241. PubMed ID: 28627045
[TBL] [Abstract][Full Text] [Related]
20. The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure.
Ozturk S; Öztürk S; Erdem FH; Erdem A; Ayhan S; Dönmez İ; Yazıcı M
J Interv Card Electrophysiol; 2016 Sep; 46(3):253-8. PubMed ID: 27039084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
